Use this button to switch between dark and light mode.

Equity Cure Rights: Q4 2022/Q1 2023 Update

May 30, 2023 (3 min read)

Equity cure rights permit an investment of cash in the borrower—typically made by a holding company, sponsor, or other shareholder—to allow the borrower to comply with financial maintenance covenants in the credit agreement, thus preventing or repairing a breach of that covenant.  The scope of equity cure rights may vary based on the type of financing and size of the transaction, and inclusion of equity cure provisions is common.

According to Market Standards, out of 266 deals surveyed in Q4 2022, 15 (5.6%) included an equity cure right (see the search in Market Standards). However, that number increased in Q1 2023—out of 196 deals surveyed, 18 deals (9.2%) included an equity cure right (see the search in Market Standards). Read this practice note to learn more about equity cure rights.

Read now »

Related Content

  • Financial Covenants and EBITDA Calculations in Credit Agreements
    Check out this practice note, which describes the use of financial covenants in credit agreements. It also discusses how EBITDA is defined in a credit agreement, which is a critical factor in calculating a borrower’s compliance with most finance covenants and its ability to incur additional indebtedness.

Practical Guidance Updates
Featuring the latest updates from your Practical Guidance account.

PRACTICAL GUIDANCE CUSTOMER EMAIL EDITION ON THE WEB

Experience results today with practical guidance, legal research, and data-driven insights—all in one place.

Experience Lexis+

Tags: